{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T04:14:27Z","timestamp":1749096867983,"version":"3.41.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T00:00:00Z","timestamp":1739923200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000864","name":"Michael J. Fox Foundation for Parkinson's Research","doi-asserted-by":"publisher","award":["6896"],"award-info":[{"award-number":["6896"]}],"id":[{"id":"10.13039\/100000864","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin. Auton. Res."],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1007\/s10286-024-01104-6","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T04:49:02Z","timestamp":1739940542000},"page":"407-419","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Heartbeat signature for predicting motor and non-motor involvement among nonparkinsonian LRRK2 G2019S mutation carriers"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8764-3583","authenticated-orcid":false,"given":"Claudia","family":"Carricarte Naranjo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Connie","family":"Marras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naomi P.","family":"Visanji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David J.","family":"Cornforth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lazaro","family":"Sanchez\u2011Rodriguez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Birgitt","family":"Sch\u00fcle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samuel M.","family":"Goldman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario","family":"Est\u00e9vez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Phyllis K.","family":"Stein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Herbert F.","family":"Jelinek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anthony E.","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andr\u00e9s","family":"Machado","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,19]]},"reference":[{"issue":"1","key":"1104_CR1","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1212\/WNL.0000000000001708","volume":"85","author":"K Marder","year":"2015","unstructured":"Marder K et\u00a0al. (2015) Age-specific penetrance of LRRK2 G2019S in the Michael J. Fox Ashkenazi Jewish LRRK2 consortium. Neurology 85(1):89\u201395","journal-title":"Neurology"},{"issue":"12","key":"1104_CR2","doi-asserted-by":"publisher","first-page":"1150","DOI":"10.1016\/S1474-4422(09)70238-8","volume":"8","author":"DW Dickson","year":"2009","unstructured":"Dickson DW et\u00a0al. (2009) Neuropathological assessment of Parkinson\u2019s disease: refining the diagnostic criteria. Lancet Neurol 8(12):1150\u20131157","journal-title":"Lancet Neurol"},{"issue":"5","key":"1104_CR3","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf A et\u00a0al. (2023) Assessment of heterogeneity among participants in the Parkinson\u2019s progression markers Initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study. Lancet Neurol 22(5):407\u2013417","journal-title":"Lancet Neurol"},{"issue":"11","key":"1104_CR4","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1002\/mds.27193","volume":"32","author":"SA Schneider","year":"2017","unstructured":"Schneider SA, Alcalay RN (2017) Neuropathology of genetic synucleinopathies with parkinsonism: review of the literature. Mov Disord 32(11):1504\u20131523","journal-title":"Mov Disord"},{"issue":"1","key":"1104_CR5","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1001\/jamaneurol.2014.2704","volume":"72","author":"LV Kalia","year":"2015","unstructured":"Kalia LV et\u00a0al. (2015) Clinical correlations with Lewy body pathology in LRRK2-related Parkinson disease. JAMA Neurol 72(1):100\u2013105","journal-title":"JAMA Neurol"},{"key":"1104_CR6","unstructured":"Solla, P., et\u00a0al. (2014) Autonomic imbalance in Parkinson\u2019s disease patients with or without LRRK2 gene mutations. in MDS 18th International Congress of Parkinson\u2019s Disease and Movement Disorders. 2014. Stockholm, Sweden: Movement Disorders."},{"issue":"6","key":"1104_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1007\/s10286-019-00632-w","volume":"29","author":"C Carricarte Naranjo","year":"2019","unstructured":"Carricarte Naranjo C et\u00a0al. (2019) Increased markers of cardiac vagal activity in leucine-rich repeat kinase 2-associated Parkinson\u2019s disease. Clin Auton Res 29(6):603\u2013614","journal-title":"Clin Auton Res"},{"issue":"6","key":"1104_CR8","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1002\/mds.26529","volume":"31","author":"N Dzamko","year":"2016","unstructured":"Dzamko N, Rowe DB, Halliday GM (2016) Increased peripheral inflammation in asymptomatic leucine-rich repeat kinase 2 mutation carriers. Mov Disord 31(6):889\u2013897","journal-title":"Mov Disord"},{"issue":"6785","key":"1104_CR9","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1038\/35013070","volume":"405","author":"LV Borovikova","year":"2000","unstructured":"Borovikova LV et\u00a0al. (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405(6785):458\u2013462","journal-title":"Nature"},{"issue":"4","key":"1104_CR10","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/S1474-4422(18)30032-2","volume":"17","author":"SY Liu","year":"2018","unstructured":"Liu SY et\u00a0al. (2018) The effect of LRRK2 mutations on the cholinergic system in manifest and premanifest stages of Parkinson\u2019s disease: a cross-sectional PET study. Lancet Neurol 17(4):309\u2013316","journal-title":"Lancet Neurol"},{"key":"1104_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.nbd.2023.106182","volume":"183","author":"L Batzu","year":"2023","unstructured":"Batzu L et\u00a0al. (2023) Increased basal forebrain volumes could prevent cognitive decline in LRRK2 Parkinson\u2019s disease. Neurobiol Dis 183:106182","journal-title":"Neurobiol Dis"},{"issue":"2","key":"1104_CR12","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1002\/cne.902140206","volume":"214","author":"M-M Mesulam","year":"1983","unstructured":"Mesulam M-M et\u00a0al. (1983) Cholinergic innervation of cortex by the basal forebrain: cytochemistry and cortical connections of the septal area, diagonal band nuclei, nucleus basalis (Substantia innominata), and hypothalamus in the rhesus monkey. J Comparative Neurol 214(2):170\u2013197","journal-title":"J Comparative Neurol"},{"key":"1104_CR13","doi-asserted-by":"crossref","unstructured":"Loewy AD (1991) Chapter 12 Forebrain nuclei involved in autonomic control, in Progress in Brain Research, G. Holstege, Editor. 1991, Elsevier. p 253\u2013268.","DOI":"10.1016\/S0079-6123(08)63055-1"},{"issue":"2","key":"1104_CR14","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/S0166-4328(98)00041-2","volume":"94","author":"GG Berntson","year":"1998","unstructured":"Berntson GG, Sarter M, Cacioppo JT (1998) Anxiety and cardiovascular reactivity: the basal forebrain cholinergic link. Behav Brain Res 94(2):225\u2013248","journal-title":"Behav Brain Res"},{"issue":"2","key":"1104_CR15","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1113\/expphysiol.2013.075192","volume":"99","author":"DF Cechetto","year":"2014","unstructured":"Cechetto DF (2014) Cortical control of the autonomic nervous system. Exp Physiol 99(2):326\u2013331","journal-title":"Exp Physiol"},{"key":"1104_CR16","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1016\/j.parkreldis.2021.09.018","volume":"91","author":"C Legault-Denis","year":"2021","unstructured":"Legault-Denis C et\u00a0al. (2021) Normal cognition in Parkinson\u2019s disease may involve hippocampal cholinergic compensation: an exploratory PET imaging study with [(18)F]-FEOBV. Parkinsonism Relat Disord 91:162\u2013166","journal-title":"Parkinsonism Relat Disord"},{"issue":"4","key":"1104_CR17","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1002\/mds.28913","volume":"37","author":"S van der Zee","year":"2022","unstructured":"van der Zee S et\u00a0al. (2022) Altered cholinergic innervation in de novo Parkinson\u2019s disease with and without cognitive impairment. Mov Disord 37(4):713\u2013723","journal-title":"Mov Disord"},{"issue":"12","key":"1104_CR18","doi-asserted-by":"publisher","first-page":"1810","DOI":"10.1152\/japplphysiol.00755.2012","volume":"113","author":"A Porta","year":"2012","unstructured":"Porta A et\u00a0al. (2012) Short-term complexity indexes of heart period and systolic arterial pressure variabilities provide complementary information. J Appl Physiol 113(12):1810\u201320","journal-title":"J Appl Physiol"},{"key":"1104_CR19","first-page":"5045","volume":"2013","author":"A Porta","year":"2013","unstructured":"Porta A et\u00a0al. (2013) Entropy-based complexity of the cardiovascular control in Parkinson disease: comparison between binning and k-nearest-neighbor approaches. Conf Proc IEEE Eng Med Biol Soc 2013:5045\u20135048","journal-title":"Conf Proc IEEE Eng Med Biol Soc"},{"issue":"9523","key":"1104_CR20","doi-asserted-by":"publisher","first-page":"1674","DOI":"10.1016\/S0140-6736(06)68735-7","volume":"367","author":"A Bauer","year":"2006","unstructured":"Bauer A et\u00a0al. (2006) Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study. Lancet 367(9523):1674\u20131681","journal-title":"Lancet"},{"key":"1104_CR21","doi-asserted-by":"publisher","first-page":"607324","DOI":"10.3389\/fphys.2020.607324","volume":"11","author":"HF Jelinek","year":"2020","unstructured":"Jelinek HF et\u00a0al. (2020) Diffusion entropy vs. multiscale and r\u00e9nyi entropy to detect progression of autonomic neuropathy. Front Physiol 11:607324. https:\/\/doi.org\/10.3389\/fphys.2020.607324","journal-title":"Front Physiol"},{"issue":"5","key":"1104_CR22","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1212\/01.WNL.0000167552.79769.b3","volume":"65","author":"C Paisan-Ruiz","year":"2005","unstructured":"Paisan-Ruiz C et\u00a0al. (2005) LRRK2 gene in Parkinson disease: mutation analysis and case control association study. Neurology 65(5):696\u2013700","journal-title":"Neurology"},{"issue":"6","key":"1104_CR23","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1007\/s10286-021-00815-4","volume":"31","author":"C Carricarte Naranjo","year":"2021","unstructured":"Carricarte Naranjo C et\u00a0al. (2021) Short-term deceleration capacity of heart rate: a sensitive marker of cardiac autonomic dysfunction in idiopathic Parkinson\u2019s disease. Clin Auton Res 31(6):729","journal-title":"Clin Auton Res"},{"issue":"2","key":"1104_CR24","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1097\/01.JGP.0000192488.66049.4b","volume":"14","author":"D Weintraub","year":"2006","unstructured":"Weintraub D et\u00a0al. (2006) Test characteristics of the 15-item geriatric depression scale and Hamilton depression rating scale in Parkinson disease. Am J Geriatr Psychiatry 14(2):169\u2013175","journal-title":"Am J Geriatr Psychiatry"},{"issue":"21","key":"1104_CR25","doi-asserted-by":"publisher","first-page":"1738","DOI":"10.1212\/WNL.0b013e3181c34b47","volume":"73","author":"S Hoops","year":"2009","unstructured":"Hoops S et\u00a0al. (2009) Validity of the MoCA and MMSE in the detection of MCI and dementia in Parkinson disease. Neurology 73(21):1738\u20131745","journal-title":"Neurology"},{"issue":"7","key":"1104_CR26","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1016\/j.sleep.2011.01.015","volume":"12","author":"T Nomura","year":"2011","unstructured":"Nomura T et\u00a0al. (2011) Utility of the REM sleep behavior disorder screening questionnaire (RBDSQ) in Parkinson\u2019s disease patients. Sleep Med 12(7):711\u2013713","journal-title":"Sleep Med"},{"issue":"6","key":"1104_CR27","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1002\/mds.27272","volume":"33","author":"TA Mestre","year":"2018","unstructured":"Mestre TA et\u00a0al. (2018) Clustering of motor and nonmotor traits in leucine-rich repeat kinase 2 G2019S Parkinson\u2019s disease nonparkinsonian relatives: a multicenter family study. Mov Disord 33(6):960\u2013965","journal-title":"Mov Disord"},{"issue":"9","key":"1104_CR28","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1002\/acn3.95","volume":"1","author":"R Saunders-Pullman","year":"2014","unstructured":"Saunders-Pullman R et\u00a0al. (2014) Olfactory identification in LRRK2 G2019S mutation carriers: a relevant marker? Ann Clin Transl Neurol 1(9):670\u2013678","journal-title":"Ann Clin Transl Neurol"},{"issue":"3","key":"1104_CR29","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1136\/jnnp.55.3.181","volume":"55","author":"AJ Hughes","year":"1992","unstructured":"Hughes AJ et\u00a0al. (1992) Accuracy of clinical diagnosis of idiopathic Parkinson\u2019s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry 55(3):181\u2013184","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"3","key":"1104_CR30","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1111\/j.1542-474X.2000.tb00396.x","volume":"5","author":"A Machado","year":"2000","unstructured":"Machado A et\u00a0al. (2000) Automatic filtering of R-R intervals for heart rate variability analysis. Ann Noninvasive Electrocardiol 5(3):255\u2013261","journal-title":"Ann Noninvasive Electrocardiol"},{"issue":"10","key":"1104_CR31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0108982","volume":"9","author":"C Gaig","year":"2014","unstructured":"Gaig C et\u00a0al. (2014) Nonmotor symptoms in LRRK2 G2019S associated Parkinson\u2019s disease. PLoS One 9(10):e108982","journal-title":"PLoS One"},{"issue":"8","key":"1104_CR32","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.1002\/mds.26614","volume":"31","author":"C Marras","year":"2016","unstructured":"Marras C et\u00a0al. (2016) Motor and nonmotor heterogeneity of LRRK2-related and idiopathic Parkinson\u2019s disease. Mov Disord 31(8):1192\u20131202","journal-title":"Mov Disord"},{"key":"1104_CR33","first-page":"2412486","volume":"2017","author":"A Bouhouche","year":"2017","unstructured":"Bouhouche A et\u00a0al. (2017) <i>LRRK2<\/i> G2019S mutation: prevalence and clinical features in moroccans with Parkinson\u2019s disease. Parkinson\u2019s Disease 2017:2412486","journal-title":"Parkinson\u2019s Disease"},{"issue":"4","key":"1104_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1212\/WNL.0b013e318227041c","volume":"77","author":"R Saunders-Pullman","year":"2011","unstructured":"Saunders-Pullman R et\u00a0al. (2011) Olfactory dysfunction in LRRK2 G2019S mutation carriers. Neurology 77(4):319\u2013324","journal-title":"Neurology"},{"issue":"7","key":"1104_CR35","doi-asserted-by":"publisher","first-page":"583","DOI":"10.1016\/S1474-4422(08)70117-0","volume":"7","author":"DG Healy","year":"2008","unstructured":"Healy DG et\u00a0al. (2008) Phenotype, genotype, and worldwide genetic penetrance of LRRK2-associated Parkinson\u2019s disease: a case-control study. Lancet Neurol 7(7):583\u2013590","journal-title":"Lancet Neurol"},{"issue":"7","key":"1104_CR36","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.parkreldis.2015.05.002","volume":"21","author":"Z Gan-Or","year":"2015","unstructured":"Gan-Or Z et\u00a0al. (2015) LRRK2 mutations in Parkinson disease; a sex effect or lack thereof? A meta-analysis. Parkinsonism Relat Disord 21(7):778\u2013782","journal-title":"Parkinsonism Relat Disord"},{"key":"1104_CR37","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3389\/fnagi.2018.00283","volume":"10","author":"L Shu","year":"2018","unstructured":"Shu L et\u00a0al. (2018) Clinical heterogeneity among LRRK2 variants in Parkinson\u2019s disease: a meta-analysis. Front Aging Neurosci 10:283","journal-title":"Front Aging Neurosci"},{"issue":"5","key":"1104_CR38","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1002\/mds.26964","volume":"32","author":"C Pont-Sunyer","year":"2017","unstructured":"Pont-Sunyer C et\u00a0al. (2017) The prodromal phase of leucine-rich repeat kinase 2-associated Parkinson disease: clinical and imaging studies. Mov Disord 32(5):726\u2013738","journal-title":"Mov Disord"},{"issue":"1","key":"1104_CR39","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41392-023-01353-3","volume":"8","author":"X Dong-Chen","year":"2023","unstructured":"Dong-Chen X et\u00a0al. (2023) Signaling pathways in Parkinson\u2019s disease: molecular mechanisms and therapeutic interventions. Signal Transduct Target Ther 8(1):73","journal-title":"Signal Transduct Target Ther"},{"issue":"Pt 12","key":"1104_CR40","doi-asserted-by":"publisher","first-page":"2777","DOI":"10.1093\/brain\/awh607","volume":"128","author":"JR Adams","year":"2005","unstructured":"Adams JR et\u00a0al. (2005) PET in LRRK2 mutations: comparison to sporadic Parkinson\u2019s disease and evidence for presymptomatic compensation. Brain 128(Pt 12):2777\u20132785","journal-title":"Brain"},{"issue":"2","key":"1104_CR41","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1001\/jamaneurol.2014.2757","volume":"72","author":"NI Bohnen","year":"2015","unstructured":"Bohnen NI et\u00a0al. (2015) Frequency of cholinergic and caudate nucleus dopaminergic deficits across the predemented cognitive spectrum of Parkinson disease and evidence of interaction effects. JAMA Neurol 72(2):194\u2013200","journal-title":"JAMA Neurol"},{"issue":"13","key":"1104_CR42","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1002\/mds.26413","volume":"30","author":"R Saunders-Pullman","year":"2015","unstructured":"Saunders-Pullman R et\u00a0al. (2015) REM sleep behavior disorder, as assessed by questionnaire, in G2019S LRRK2 mutation PD and carriers. Mov Disord 30(13):1834\u20131839","journal-title":"Mov Disord"},{"issue":"7","key":"1104_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0132368","volume":"10","author":"C Pont-Sunyer","year":"2015","unstructured":"Pont-Sunyer C et\u00a0al. (2015) Sleep disorders in Parkinsonian and nonparkinsonian LRRK2 mutation carriers. PLoS ONE 10(7):e0132368","journal-title":"PLoS ONE"},{"key":"1104_CR44","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/978-3-319-49969-7_2","volume":"14","author":"M Kestenbaum","year":"2017","unstructured":"Kestenbaum M, Alcalay RN (2017) Clinical features of LRRK2 carriers with Parkinson\u2019s disease. Adv Neurobiol 14:31\u201348","journal-title":"Adv Neurobiol"},{"issue":"6","key":"1104_CR45","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1038\/s41582-021-00486-9","volume":"17","author":"D Berg","year":"2021","unstructured":"Berg D et\u00a0al. (2021) Prodromal Parkinson disease subtypes\u2014Key to understanding heterogeneity. Nat Rev Neurol 17(6):349\u2013361","journal-title":"Nat Rev Neurol"},{"issue":"7","key":"1104_CR46","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1002\/mds.26213","volume":"30","author":"A Mirelman","year":"2015","unstructured":"Mirelman A et\u00a0al. (2015) Nonmotor symptoms in healthy Ashkenazi Jewish carriers of the G2019S mutation in the LRRK2 gene. Mov Disord 30(7):981\u2013986","journal-title":"Mov Disord"},{"issue":"6","key":"1104_CR47","doi-asserted-by":"publisher","first-page":"966","DOI":"10.1002\/mds.27342","volume":"33","author":"A Mirelman","year":"2018","unstructured":"Mirelman A et\u00a0al. (2018) Application of the movement disorder society prodromal criteria in healthy G2019S-LRRK2 carriers. Mov Disord 33(6):966\u2013973","journal-title":"Mov Disord"},{"issue":"4","key":"1104_CR48","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1212\/WNL.0b013e318227042d","volume":"77","author":"C Marras","year":"2011","unstructured":"Marras C et\u00a0al. (2011) Phenotype in parkinsonian and nonparkinsonian LRRK2 G2019S mutation carriers. Neurology 77(4):325\u2013333","journal-title":"Neurology"},{"issue":"5","key":"1104_CR49","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1002\/mds.27974","volume":"35","author":"H Iwaki","year":"2020","unstructured":"Iwaki H et\u00a0al. (2020) Penetrance of Parkinson\u2019s disease in LRRK2 p.G2019S carriers is modified by a polygenic risk score. Mov Disord 35(5):774\u2013780","journal-title":"Mov Disord"},{"key":"1104_CR50","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/1741-7015-6-32","volume":"6","author":"JC Latourelle","year":"2008","unstructured":"Latourelle JC et\u00a0al. (2008) The Gly2019Ser mutation in LRRK2 is not fully penetrant in familial Parkinson\u2019s disease: the GenePD study. BMC Med 6:32","journal-title":"BMC Med"},{"issue":"10","key":"1104_CR51","doi-asserted-by":"publisher","first-page":"1793","DOI":"10.1002\/mds.23853","volume":"26","author":"C Klein","year":"2011","unstructured":"Klein C et\u00a0al. (2011) The curious case of phenocopies in families with genetic Parkinson\u2019s disease. Mov Disord 26(10):1793\u20131802","journal-title":"Mov Disord"},{"issue":"7","key":"1104_CR52","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1212\/WNL.0b013e31828250d6","volume":"80","author":"M Sierra","year":"2013","unstructured":"Sierra M et\u00a0al. (2013) Olfaction and imaging biomarkers in premotor LRRK2 G2019S-associated Parkinson disease. Neurology 80(7):621\u2013626","journal-title":"Neurology"},{"issue":"4","key":"1104_CR53","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/S1474-4422(21)00377-X","volume":"21","author":"NI Bohnen","year":"2022","unstructured":"Bohnen NI et\u00a0al. (2022) Cholinergic system changes in Parkinson\u2019s disease: emerging therapeutic approaches. Lancet Neurol 21(4):381\u2013392","journal-title":"Lancet Neurol"},{"issue":"1","key":"1104_CR54","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1161\/01.HYP.0000250939.71343.7c","volume":"49","author":"F Barbic","year":"2007","unstructured":"Barbic F et\u00a0al. (2007) Early abnormalities of vascular and cardiac autonomic control in Parkinson\u2019s disease without orthostatic hypotension. Hypertension 49(1):120\u2013126","journal-title":"Hypertension"},{"issue":"9","key":"1104_CR55","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1093\/europace\/euv015","volume":"17","author":"R Sassi","year":"2015","unstructured":"Sassi R et\u00a0al. (2015) Advances in heart rate variability signal analysis: joint position statement by the e-cardiology ESC working group and the European heart rhythm association co-endorsed by the asia pacific heart rhythm society. Europace 17(9):1341\u20131353","journal-title":"Europace"},{"issue":"12","key":"1104_CR56","doi-asserted-by":"publisher","first-page":"1921","DOI":"10.1007\/s11517-016-1486-9","volume":"54","author":"Q Pan","year":"2016","unstructured":"Pan Q et\u00a0al. (2016) Do the deceleration\/acceleration capacities of heart rate reflect cardiac sympathetic or vagal activity? A model study. Med Biol Eng Comput 54(12):1921\u20131933","journal-title":"Med Biol Eng Comput"},{"issue":"12","key":"1104_CR57","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCEP.120.008659","volume":"13","author":"L Zheng","year":"2020","unstructured":"Zheng L et\u00a0al. (2020) The diagnostic value of cardiac deceleration capacity in vasovagal syncope. Circ Arrhythm Electrophysiol 13(12):e008659","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"6","key":"1104_CR58","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10286-009-0019-0","volume":"19","author":"P Singh","year":"2009","unstructured":"Singh P et\u00a0al. (2009) Autonomic tone and C-reactive protein: a prospective population-based study. Clin Auton Res 19(6):367\u2013374","journal-title":"Clin Auton Res"},{"issue":"1","key":"1104_CR59","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1038\/s41598-022-05799-3","volume":"12","author":"S Magawa","year":"2022","unstructured":"Magawa S et\u00a0al. (2022) Fetal heart rate variability is a biomarker of rapid but not progressive exacerbation of inflammation in preterm fetal sheep. Sci Rep 12(1):1771","journal-title":"Sci Rep"},{"issue":"6","key":"1104_CR60","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1109\/TBME.2016.2600160","volume":"64","author":"A Porta","year":"2017","unstructured":"Porta A et\u00a0al. (2017) Are nonlinear model-free conditional entropy approaches for the assessment of cardiac control complexity superior to the linear model-based one? IEEE Trans Biomed Eng 64(6):1287\u20131296","journal-title":"IEEE Trans Biomed Eng"}],"container-title":["Clinical Autonomic Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-024-01104-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10286-024-01104-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10286-024-01104-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T16:02:03Z","timestamp":1749052923000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10286-024-01104-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,19]]},"references-count":60,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["1104"],"URL":"https:\/\/doi.org\/10.1007\/s10286-024-01104-6","relation":{},"ISSN":["0959-9851","1619-1560"],"issn-type":[{"type":"print","value":"0959-9851"},{"type":"electronic","value":"1619-1560"}],"subject":[],"published":{"date-parts":[[2025,2,19]]},"assertion":[{"value":"11 July 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}